Osteoarthritis of the Shoulder Pain Study

This is a multi-center, randomized, double-blind, parallel-group study in subjects with glenohumeral (shoulder) OA.

A Phase 3, Multicenter, Randomized, Double-blind, Single-dose Study to Evaluate the Efficacy and Safety of ZILRETTA (FDA approved drug) in Subjects with Glenohumeral Osteoarthritis.

Criteria

You may qualify for the study if you meet the following requirements:

  • Be aged 50 to 80.

  • Have Shoulder OA pain for at least 3 months duration.

  • Willing to undergo a drug test and not use exclusionary medications during study.

  • Not have Osteoarthritis related pain in both shoulders. Pain must be in only one shoulder.

  • Have been diagnosed with adhesive capsulitis within the past year before starting study.

Note, additional criteria apply.

About PRO

Physicians’ Research Options (PRO) is an experienced Clinical Research Company dedicated to the performance of Phase II, III and IV Pharmaceutical and Pilot/Pivotal Medical Device clinical trials. Our staff experience totals over 60 years in Clinical / Medical Research.

Our staff recruits for and manages studies in Utah and Colorado.

Call us or fill out the form below to inquire about participating.

Draper, UT Office: (801) 352-9228